ALK INHIBITORS SAFETY PROFILE IN PEDIATRIC PATIENTS TREATED FOR AN ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA: REAL LIFE EXPERIENCE AMONG A FRENCH COHORT. (October 2022)

• Record Type: Journal Article
• Authors: d'Hautefeuille, C.; Abbou, S.; El-Gourari-Miaz, L.; Lambilliotte, A.; Renard, C.; Landman-Parker, J.; Gourdon, S.; Metayer, L.; Leblanc, T.; Pacquement, H.; Rabian, F.; Verschuur, A.; Brasme, J.; Millot, F.; Pagnier, A.; Buchbinder, N.; Rorhlich, P.; Minard-Colin, V.; Brugières, L.; Ducassou, S.; Rigaud, C.
• Is Part Of: Leukemia research. Volume 121(2022)Supplement
• Page Start: S68
• Page End: S69
• Publication Date: 2022-10
• Subjects: Leukemia -- Periodicals; Leukemia -- Periodicals; Leucémie -- Périodiques; Leukemia; Periodicals; Electronic journals; Electronic journals; 616.9941905
• DOI: 10.1016/S0145-2126(22)00308-3
• Languages: English
• ISSNs: 0145-2126